Among 24 droxidopa and 27 placebo recipients , mean OHQ composite-score change at Week 8 was -2.2 versus -2.1 ( p = 0.98 ) ; in response to this pre-planned futility analysis , the study was temporarily stopped and all data from these patients were considered exploratory .